Percutaneous Aortic Valve IDE Approval Rests On Clearer Criteria – Edwards
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will work with FDA on crafting an acceptable definition for "high-risk patients" to meet an investigational device exemption approval goal of early 2005 for its percutaneous aortic valve, the firm said in a Dec. 3 investor conference